US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
pharma · Cholestatic liver disease · Cystic Fibrosis · PRQR
ProQR Therapeutics N.V
ProQR Therapeutics N.V.
ProQR Therapeutics N.V drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Leiden, NL HQ
2012 Founded
204 Employees
Public company Type
PRQR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Leiden, NL
- Founded
- 2012
- Employees
- 204
- Programs
- 6
- Drugs
- 2
- Patents
- 19
ProQR Therapeutics N.V pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
ProQR Therapeutics N.V drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to ProQR Therapeutics N.V in public FDA and regional records.